Ambrocio Oy is a Finnish company established in 2019, specializing in advanced medical implants. Leveraging additive manufacturing, they create bioactive and bioresorbable neurosurgical implants tailored for bone regeneration and cranio-maxillofacial reconstruction. Their patented technology integrates durable PEEK materials and bioactive glass to enhance biocompatibility and tissue integration. Based in Turku, Ambrocio focuses on sustainable, innovative solutions to improve personalized patient care globally.